Bilastin-Mepha 20 mg, Tabletten - 30 Swissmedic Key 68002002 Registration Holder Mepha Pharma AG Name Bilastin-Mepha 20 mg, Tabletten Date of registration 01.11.2021 Original/Generic Generic Introduction of Sequence 01.11.2021 ATC-Classification Bilastine (R06AX29) Revision date WHO WHO-DDD Valid until 31.10.2026 Index Therapeuticus (BSV) 07.13.10. Show package size 30 Index Therapeuticus (Swissmedic) 07.13.10. Description Swissmedic categorie. D SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 6.10 Limitation No Deductible 10 % Consumer price 11.25 Feedback FB Daily cost GTIN 7680680020029 Medication Code Synthetika Pharmacode Disponibility
Composition bilastinum 20 mg, cellulosum microcristallinum, mannitolum, silica colloidalis anhydrica, magnesii stearas, carboxymethylamylum natricum A corresp. natrium 0.21 mg, magnesii aluminii silicas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Bilastinum 20 mg
BAG: Active Agent Dose Bilastinum 20 mg
Inactive agents Carboxymethylamylum Natricum A Cellulosum Microcristallinum Magnesii Aluminii Silicas Magnesii Stearas Mannitol Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 06.06.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
